Evidence map›Paper›PMID 30413076›Full record

ReviewPharmaceutics2018

A Review on Liquid Chromatography-Tandem Mass Spectrometry Methods for Rapid Quantification of Oncology Drugs.

Andrea Li-Ann Wong, Xiaoqiang Xiang, Pei Shi Ong, Ee Qin Ying Mitchell, Nicholas Syn, Ian Wee, Alan Prem Kumar, Wei Peng Yong, Gautam Sethi, Boon Cher Goh and 2 more

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Overview on Strategies and Assays for Antibiotic Discovery.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Development and validation of a LC-MS/MS method for in vivo quantification of meta-iodobenzylguanidine (mIBG).Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2021
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrea Li-Ann WongCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore. andrea_la_wong@nuhs.edu.sg.
Xiaoqiang XiangSchool of Pharmacy, Fudan University, Shanghai 201203, China. xiangxq@fudan.edu.cn.
Pei Shi OngDepartment of Pharmacy, National University of Singapore, Singapore 117543, Singapore. phaops@nus.edu.sg.
Ee Qin Ying MitchellDepartment of Pharmacy, National University of Singapore, Singapore 117543, Singapore. mitchell.ee.q.y@sgh.com.sg.
Nicholas SynCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore. nicholassyn@gmail.com.
Ian WeeCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore. ianwee180894@outlook.com.
Alan Prem KumarCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore. csiapk@nus.edu.sg.ORCID 0000-0002-3754-5712
Wei Peng YongCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore. wei_peng_yong@nuhs.edu.sg.
Gautam SethiDepartment of Pharmacology, Yong Loo Lin School of Medicine, Singapore 117597, Singapore. phcgs@nus.edu.sg.
Boon Cher GohCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore. phcgbc@nus.edu.sg.
Paul Chi-Lui HoDepartment of Pharmacy, National University of Singapore, Singapore 117543, Singapore. phahocl@nus.edu.sg.
Lingzhi WangCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore. csiwl@nus.edu.sg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last decade, the tremendous improvement in the sensitivity and also affordability of liquid chromatography-tandem mass spectrometry (LC-MS/MS) has revolutionized its application in pharmaceutical analysis, resulting in widespread employment of LC-MS/MS in determining pharmaceutical compounds, including anticancer drugs in pharmaceutical research and also industries. Currently, LC-MS/MS has been widely used to quantify small molecule oncology drugs in various biological matrices to support preclinical and clinical pharmacokinetic studies in R&D of oncology drugs. This mini-review article will describe the state-of-the-art LC-MS/MS and its application in rapid quantification of small molecule anticancer drugs. In addition, efforts have also been made in this review to address several key aspects in the development of rapid LC-MS/MS methods, including sample preparation, chromatographic separation, and matrix effect evaluation.

Indexed as

LC-MS/MSoncology drugsquantificationrapid

Identifiers

PMID30413076
PMCPMC6321130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.